Prostate Cancer Prognostic Factors Among Asian Patients Born in the US Compared to Those Born Abroad

详细信息    查看全文

• 作者：Junjun Xu ; Michael Goodman ; Ahemdin Jemal…
• 关键词：Prostate cancer ; Asian Americans ; Immigrants ; Gleason score ; PSA
• 刊名：Journal of Immigrant and Minority Health
• 出版年：2015
• 出版时间：June 2015
• 年：2015
• 卷：17
• 期：3
• 页码：625-631
• 全文大小：356 KB
• 参考文献：1.McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep. 2004;119(2):174-6.PubMed Central PubMed
  2.Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-9.View Article PubMed
  3.Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-17.View Article PubMed
  4.Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079-2.View Article PubMed
  5.Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst. 1995;87(9):652-1.View Article PubMed
  6.Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol. 1999;161(1):152-.View Article PubMed
  7.A Community of Contrasts Asian Americans in the United States 2011. Asian American Center for Advancing Justice: Washington DC; 2011.
  8.Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, et al. Cancer incidence trends among Asian American populations in the United States, 1990-008. J Natl Cancer Inst. 2013;105(15):1096-10.View Article PubMed Central PubMed
  9.Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Am J Public Health. 2003;93(10):1753-.View Article PubMed Central PubMed
  10.Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology. 2007;69(6):1095-01.View Article PubMed Central PubMed
  11.Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324(17):1156-1.View Article PubMed
  12.Kim HM, Goodman M, Kim BI, Ward KC. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER. J Registry Manag. 2011;38(3):120-1.PubMed
  13.Surveillance E, and End Results (SEER) Program (www.?seer.?cancer.?gov ) SEER*Stat Database: incidence—SEER 9 Regs Research Data, Nov 2011 Sub (1973-010)?<Katrina/Rita Population Adjustment>—Linked To County Attributes—Total U.S., 1969-010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission.
  14.Adamo MBJC, Ruhl JL, Dickie LA. SEER program coding and staging manual. Bethesda: National Cancer Institute; 2013.
  15.Gomez SL, Glaser SL, Kelsey JL, Lee MM. Bias in completeness of birthplace data for Asian groups in a population-based cancer registry (United States). Cancer Causes Control. 2004;15(3):243-3.View Article PubMed
  16.Cancer AJCO. Collaborative staging manual and coding instruction. American Joint Commission on Cancer and US Department of Health and Human Services: Bethesda, MD; 2007.
  17.Ross LE, Taylor YJ, Richardson LC, Howard DL. Patterns in prostate-specific antigen test use and digital rectal examinations in the behavioral risk factor surveillance system, 2002-006. J Natl Med Assoc. 2009;101(4):316-4.PubMed
  18.Merrill RM. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. Prev Med. 2001;33(6):646-2.View Article PubMed
  19.Jemal A, Ward E, Wu X, Martin HJ, McLaughlin CC, Thun MJ. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev. 2005;14(3):590-.View Article PubMed
  20.McLafferty S, Wang F. Rural reversal? Rural-urban disparities in late-stage cancer risk in Illinois. Cancer. 2009;115(12):2755-4.View Article PubMed Central PubMed
  21.Goodman M, Ward KC, Osunkoya AO, Datta MW, Luthringer D, Young AN, et al. Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer. Prostate. 2012;72(13):1389-8.View Article PubMed Central PubMed
  22.Society AC. Cancer prevention and early detection facts and figures. American Cancer Society 2012; 2012.
  23.Kandula NR, Wen M, Jacobs EA, Lauderdale DS. Low rates of colorectal, cervical, and breast cancer screening in Asian Americans compared with non-Hispanic whites: cultural influences or access to care? Cancer. 2006;107(1):184-2.View Article PubMed
  24.Lee-Lin F, Pett M, Menon U, Lee S,
• 作者单位：Junjun Xu (1)
  Michael Goodman (1)
  Ahemdin Jemal (2)
  Stacey A. Fedewa (1)
  
  1. Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Road, NE, Atlanta, GA, 30322, USA
  2. Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA
  
• 刊物主题：Public Health; Sociology, general; Private International Law, International & Foreign Law, Comparative Law;
• 出版者：Springer US
• ISSN：1557-1920

文摘

US surveillance data indicate that incidence of prostate cancer differs by place of birth among Asian men. However, it is less clear if the prognostic factors for prostate cancer also differ by place of birth. The study included 7,824 Asian prostate cancer patients diagnosed between 2004 and 2009 and reported to the Surveillance Epidemiology and End Results (SEER) program. Logistic regression models were used to evaluate the relation of place of birth (foreign born vs. US born) to three outcomes: prostate specific antigen (PSA) level, Gleason score, and T classification, adjusting for age, marital status, Rural–Urban Continuum Code, and SEER registry. All outcome variables were binary using different cutoffs: ?, ?0 and ?0?ng/ml for PSA; ? and ? for Gleason score; and ≥T2 and ≥T3 for T classification. Elevated PSA was more common among foreign born Asian men regardless of the cut point used. In the analysis comparing foreign born versus US born patients by ethnic group, the association with PSA was most pronounced at cut point of ?0?ng/ml for Chinese men (OR 1.68, 95?% CI 1.02-.75), and at cut point of ??ng/ml for Japanese men (OR 2.73, 95?% CI 1.20-.21). A statistically significant association with Gleason score was only found for Japanese men and only for the cutoff ? (OR 1.71, 95?% CI 1.12-.61). There was no difference in clinical T classification between foreign-born and US-born Asian men. Inclusion of cases with missing place of birth or restriction of data to those who underwent radical prostatectomy did not substantially change the results. The data suggest that foreign-born Asian prostate cancer patients may have moderately elevated PSA levels at diagnosis compared with their US born counterparts. For the other prognostic markers, the associations were less consistent and did not form a discernible pattern.